KRISTEN THOMAS: Open Payments
NPI 1871938415 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $110 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 1 | $41 |
| Abbott Laboratories | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| GENZYME CORPORATION | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Lilly USA, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $13 |
Products named: NUCALA, VOQUEZNA, FREESTYLE LIBRE 3, NEFFY, DUPIXENT, CAPLYTA, MOUNJARO, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
